Dr. Shruti Zaveri, MD

Dr. Zaveri practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Zaveri's NPI, 1124411855, was assigned on March 5, 2015. Dr. Zaveri graduated from Feinberg School of Medicine in 2017. Dr. Zaveri holds Texas license T7091.

Dr. Zaveri's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Zaveri's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. Dr. Zaveri is also affiliated with The University of Texas MD Anderson Cancer Center. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Zaveri to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zaveri practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Zaveri's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Zaveri is board certified in surgery by the American Board of Surgery. Dr. Zaveri is licensed in Texas.

CMS data shows 47 Medicare services from Dr. Zaveri across 3 procedure codes in 2024, for 33 Medicare patients. Medicare paid $4,737 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 33 Medicare patients who saw Dr. Zaveri in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have cancer, and 70% have high cholesterol. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zaveri's median patient age at 61, with 94% women.

In 2024, Dr. Zaveri wrote 53 Medicare Part D claims for 25 patients. 100% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $24 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Zaveri for performance year 2024, reported as part of a group. Dr. Zaveri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Zaveri, published from 2017 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Analgesics, Opioid, Breast Neoplasms and Pain, Postoperative. Dr. Zaveri has published most often in Ann Surg Oncol. Dr. Zaveri's most frequent co-authors are Celia M. Divino, MD, Tamar Bella Nobel and Anya Miriam Romanoff, MD.

CMS Open Payments shows 5 general payments to Dr. Zaveri from 4 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 61% of the total. Leica Microsystems Inc. paid the most, $305.

Dr. Zaveri graduated from Feinberg School of Medicine in 2017.

Dr. Zaveri is in network with 19 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.